| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/23/2010 | US7666630 Use in detergents, degumming, and baking; producing such a polypeptide by cultivating a recombinant host cell comprising a nucleic acid construct comprising a polynucleotide encoding the polypeptide under conditions conducive for producing the polypeptide |
| 02/23/2010 | US7666629 Trypsinogen protein for use as tool in polypeptide analysis |
| 02/23/2010 | US7666628 Preparation of heterologous proteins on oil bodies |
| 02/23/2010 | US7666627 Folded recombinant catalytic fragments of multidomain serine proteases, preparation and uses thereof |
| 02/23/2010 | US7666626 P4 variant protein that has reduced enzymatic activity and that induces antibody to wild-type P4 protein and/or has good bactericidal activity against non-typable H. influenzae (NTHi) |
| 02/23/2010 | US7666624 Chemically conjugating a peptide of interest to a heterologous peptide that has been expressed on the coat protein of a cowpea mosaic virus to generate a conjugate and administering the conjugate to a host animal to increase the level of TH1-type immune response |
| 02/23/2010 | US7666623 Method for producing alpha-1, 6-branched alpha-1, 4-glucans from sucrose |
| 02/23/2010 | US7666622 Nucleic acid encoding monomeric fusion polypeptide R1-M-L-M, wherein R1 is a ligand-binding domain of an interleukin receptor capable of binding an interleukin target ligand, M is a self-associating component, and L is a linker; therapy for cancer or diabetic retinopathy |
| 02/23/2010 | US7666621 Has an apparent molecular weight of 42,000 Daltons; fusion protein of the protein D bound to a polypeptide, carbohydrate, or matrix; prepared by providing a non-human host containing a plasmid or phage comprising a DNA nucleotide sequence and expressing the encoded protein D |
| 02/23/2010 | US7666619 Compounds and methods for regulating bacterial growth and pathogenesis |
| 02/23/2010 | US7666616 Expression vector comprising reporter enzyme for enhanced expression in microorganism; improving heterologouus gene expression in host cells |
| 02/23/2010 | US7666613 psychiatric disorders; serine protease; genetic engineering; schizophrenia |
| 02/23/2010 | US7666611 Lysophosphatidic acid receptor |
| 02/23/2010 | US7666610 Expressing transporters on viral envelopes |
| 02/23/2010 | US7666609 Method and composition for diagnosis of melanocytic lesions |
| 02/23/2010 | US7666606 Protein- protein interaction detection system using fluorescent protein microdomains |
| 02/23/2010 | US7666604 Modified soluble T cell receptor |
| 02/23/2010 | US7666603 Breast cancer related protein, gene encoding the same, and method of diagnosing breast cancer using the protein and gene |
| 02/23/2010 | US7666601 Membrane protein; point mutations; antibodies; food processing and bitterness; phenotype analysis |
| 02/23/2010 | US7666582 Immunoglobulin G-degrading enzyme for use as tool in diagnosis, prevention and treatment of streptococcal infection |
| 02/23/2010 | US7666441 Nucleic acids encoding peptides having at least one biological activity of Can f I or Can f II, protein allergens of the species Canis familiaris; suitable for pharmaceutical administration or methods of diagnosing sensitivity to dog dander |
| 02/23/2010 | US7666436 Pertussis toxin mutants, Bordetella strains capable of producing such mutants and their use in the development of antipertussis vaccines |
| 02/23/2010 | US7666434 Screening blood and identifying immunologically active antigen of herpes simplex virus (HSV) which attacks skin; diagnosing viral infection; viricides |
| 02/23/2010 | US7666433 Recombinant RSV strains with altered G protein |
| 02/23/2010 | US7666430 Polypeptides and polynucleotides for enhancing immune reactivity to HER-2 protein |
| 02/23/2010 | US7666429 Nucleic acids encoding a house dust mite allergen Der P III, and uses therefor |
| 02/23/2010 | US7666428 Recombinant allergen with reduced IgE binding but undiminished T-cell antigenicity |
| 02/23/2010 | US7666425 Use of antibodies or binding portions thereof, probes, ligands, or other biological agents which either recognize an extracellular domain of prostate specific membrane antigen or bind to and are internalized with prostate specific membrane antigen |
| 02/23/2010 | US7666423 Methods of inhibiting tumor cell aggressiveness using the microenvironment of human embryonic stem cells |
| 02/23/2010 | US7666422 Methods for the treatment of cancer using anti-CD40 antibodies |
| 02/23/2010 | US7666419 Anti-CCR5 antibody |
| 02/23/2010 | US7666418 Method for treating Th2-mediated disease |
| 02/23/2010 | US7666415 Production and use of novel peptide-based agents for use with bi-specific antibodies |
| 02/23/2010 | US7666414 Using modified anti-PSMA antibodies, or fragments thereof, to bind to human PSMA with high affinity and specificity; can be used as diagnostic, prophylactic, or therapeutic agents in vivo and in vitro |
| 02/23/2010 | US7666412 Methods for the treatment of neoplastic disorders with anti-caveolin agents |
| 02/23/2010 | US7666405 Deleted adenovirus vectors and methods of making and administering the same |
| 02/23/2010 | US7666403 Mutant interferon α protein and use thereof |
| 02/23/2010 | US7666401 Compositions comprising a ligand of Chemerin R |
| 02/23/2010 | CA2416949C Non-human animal model unresponsive to mycoplasma derived lipoprotein/lipopeptide |
| 02/23/2010 | CA2389743C Recombinant sendai virus vector for introducing exogenous genes to airway epithelia |
| 02/23/2010 | CA2355834C Human akt-3 |
| 02/23/2010 | CA2347521C Method for producing chiral carboxylic acids from nitriles with the assistance of a nitrilase or microorganisms which contain a gene for the nitrilase |
| 02/23/2010 | CA2346620C Improvement of biological production of carotenoids and biological materials therefor |
| 02/23/2010 | CA2344173C Immunogenic liposome compositions |
| 02/23/2010 | CA2315277C Pharmaceutical compositions containing the long pentraxin ptx3 |
| 02/23/2010 | CA2303390C Lkta deletion mutant of p. haemolytica |
| 02/23/2010 | CA2294760C Vector for expression of heterologous protein and methods for extracting recombinant protein and for purifying isolated recombinant insulin |
| 02/23/2010 | CA2257852C Transgenic non-human mammals with progressive neurologic disease |
| 02/23/2010 | CA2198899C Methods for producing antibody libraries using universal or randomized immunoglobulin light chains |
| 02/23/2010 | CA2138999C Cloning and expression of gonadotropin-releasing hormone receptor |
| 02/23/2010 | CA2125449C Vector and mammalian cell line having improved productivity |
| 02/18/2010 | WO2010019921A2 Biomarkers for diagnosis and treatment of chronic lymphocytic leukemia |
| 02/18/2010 | WO2010019872A1 Plants with altered root architecture, related constructs and methods involving genes encoding protein phophatase 2c (pp2c) polypeptides and homologs thereof |
| 02/18/2010 | WO2010019838A2 Stress tolerant transgenic crop plants |
| 02/18/2010 | WO2010019813A2 Production of fatty actds by genetically modified photosynthetic organisms |
| 02/18/2010 | WO2010019619A1 Method and composition for controlling gene expression |
| 02/18/2010 | WO2010019571A2 A novel chorismate mutase gene from the potato cyst nematode globodera rostochiensis |
| 02/18/2010 | WO2010019569A1 Methods for the production of ips cells |
| 02/18/2010 | WO2010019487A1 Improved vectors and yeast strains for protein production: ca2+ atpase overexpression |
| 02/18/2010 | WO2010019437A1 Alphavirus packaging cell lines |
| 02/18/2010 | WO2010019262A2 Polyvalent vaccine |
| 02/18/2010 | WO2010019257A2 Prodrug activation in cancer cells using molecular switches |
| 02/18/2010 | WO2010019243A1 Methods for treating viral infections |
| 02/18/2010 | WO2010019236A1 Methods for treating spinal muscular atrophy |
| 02/18/2010 | WO2010019006A2 Expression vector containing the major envelope protein p9 of cystovirus phi6 as a fusion expression partner, and process for producing a membrane protein using same |
| 02/18/2010 | WO2010018870A1 Polypeptide marker for diagnosis of arteriosclerosis, method for detection of arteriosclerosis by using the maker or the like, and kit for diagnosis of arteriosclerosis |
| 02/18/2010 | WO2010018859A1 Modified biotin-binding protein |
| 02/18/2010 | WO2010018847A1 Recombinant protein-s composition |
| 02/18/2010 | WO2010018846A1 Drug containing antibody composition specifically binding to ganglioside gm2 |
| 02/18/2010 | WO2010018845A1 Method for promotion of branch formation, dwarfing, sterility and promotion of multiple flower bud formation of plant |
| 02/18/2010 | WO2010018840A1 Probe for visualizing nerve activity |
| 02/18/2010 | WO2010018764A1 Anti-angiogenic agent, and screening method and screening kit for same |
| 02/18/2010 | WO2010018731A2 A mammalian rna dependent rna polymerase |
| 02/18/2010 | WO2010018693A1 Method for accelerating plant lipid synthesis using pprtp gene |
| 02/18/2010 | WO2010018652A1 Agent for promoting neuronal differentiation and method therefor |
| 02/18/2010 | WO2010018598A1 Hybrid-type histidine kinase gene isolated from indica rice ir64 |
| 02/18/2010 | WO2010018592A2 Lethal gene as a tool for zero background cloning |
| 02/18/2010 | WO2010018444A2 An expression vector and a method thereof |
| 02/18/2010 | WO2010018251A1 Method for improving the expression of proteins in chloroplasts |
| 02/18/2010 | WO2010018234A1 Transgenic plants |
| 02/18/2010 | WO2010018200A1 Method for the isolation of nucleic acids and test kit |
| 02/18/2010 | WO2010018196A1 Increased production of pantothenate (vitamin b5) |
| 02/18/2010 | WO2010018136A1 Minigene comprising htpa signal peptide, t-cell epitopes, e. coli ltb and furin sensitive linkers |
| 02/18/2010 | WO2010017962A1 Modified thromboxane a2 receptor promoter sequence |
| 02/18/2010 | WO2010017819A1 EFFICIENT CELL CULTURE SYSTEM FOR HEPATITIS C VIRUS GENOTYPE 7a |
| 02/18/2010 | WO2010017653A1 Gq protein competitive inhibitory polypeptides, preparation methods and uses thereof |
| 02/18/2010 | WO2010017595A1 Variant domain antibodies |
| 02/18/2010 | WO2009157771A3 Antibody producing non-human mammals |
| 02/18/2010 | WO2009155324A3 Pigf-1 assay and kits and components thereof |
| 02/18/2010 | WO2009153302A3 Rna antagonists targeting hsp70-2 |
| 02/18/2010 | WO2009149921A8 Inhibition of hrp-3 using modified oligonucleotides |
| 02/18/2010 | WO2009149578A4 Use of gene in the synthesis of astaxanthin |
| 02/18/2010 | WO2009149091A9 Controllable assembly and disassembly of nanoparticle systems via protein and dna agents |
| 02/18/2010 | WO2009147179A3 Process of producing male sterile monocotyledonous plants |
| 02/18/2010 | WO2009145838A3 Cellular production of glucaric acid |
| 02/18/2010 | WO2009144358A3 Recombinant wine yeasts |
| 02/18/2010 | WO2009132351A9 Anti-sense microrna expression vectors |
| 02/18/2010 | WO2009129523A3 Compositions and methods for nucleic acid delivery |
| 02/18/2010 | WO2009129505A3 Compositions, methods, and kits using synthetic probes for determining the presence of a target nucleic acid |
| 02/18/2010 | WO2009128953A3 Genetic variants in a hypertension susceptibility gene stk39 and uses thereof |